综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / China Development Forum 2026

Novartis announces further China investment

By Li Jing | chinadaily.com.cn | Updated: 2026-03-23 14:36
Share
Share - WeChat

Swiss pharmaceutical company Novartis is to expand its research and development, manufacturing capacity and operations footprint in China, with planned investment of more than 3.3 billion yuan ($460 million), a gathering in Beijing has heard.

The announcement came as the China Development Forum annual meeting opened in Beijing on Sunday, with Vas Narasimhan, the chief executive officer of Novartis, attending for the eighth time.

"China is critical to Novartis' long-term development and innovation," Narasimhan said, adding that the Basel-based company will continue to bring innovative medicines to Chinese patients and aims to be a trusted healthcare partner in the country.

Novartis said China has become its second-largest market globally, and the company plans to launch a large-scale investment and expansion program this year to strengthen innovation and manufacturing capacity in the country.

Its Changping plant in Beijing, established in 1987, is a major production site in the company's global manufacturing network. The facility has started a new round of expansion and upgrade projects, with planned investment of about 1.5 billion yuan to build new facilities and introduce new sterile preparation, liquid filling and packaging technologies.

The company's Shanghai campus, which serves as Novartis' China headquarters, will mark its 10th year of operations this year. Novartis plans to jointly invest 1.8 billion yuan with partners to launch the second phase of the project.

Novartis pioneers radioligand therapy, which treats certain cancers, with its targeted PSMA radioligand therapy receiving approval in China for two indications in November last year.

Major construction is complete on the company's radioligand manufacturing facility in Haiyan county, Zhejiang province - the first of its kind in China. Once the site, which has seen an investment of 600 million yuan, reaches full production capacity, it will help reduce waiting time for Chinese patients seeking radioligand therapy.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
永顺县| 岐山县| 龙海市| 皋兰县| 惠州市| 象州县| 垣曲县| 慈溪市| 青岛市| 安龙县| 竹溪县| 江永县| 安福县| 高尔夫| 北流市| 洪泽县| 潜江市| 达孜县| 武乡县| 乐都县| 彩票| 宜宾市| 浦城县| 保德县| 大竹县| 汝南县| 梁平县| 错那县| 巴林左旗| 英山县| 阿巴嘎旗| 巨野县| 七台河市| 休宁县| 滦平县| 江口县| 潞城市| 龙口市| 合山市| 黔江区| 安宁市|